TGF-beta 1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereastolerance induction also required inflammatory cytokines down-regulation
K. Gagne et al., TGF-beta 1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereastolerance induction also required inflammatory cytokines down-regulation, EUR J IMMUN, 31(10), 2001, pp. 3111-3120
Heart allograft tolerance in adult recipients can be induced in the LEW.1W
to LEW.1A congeneic strain combination by pre-graft donor-specific blood tr
ansfusion (DST). Long-term survivors accept LEW.1W graft but reject third p
arty skin grafts. As tolerant recipients of heart allografts showed an incr
ease in anti-donor class II antibodies, we hypothesize that these antibodie
s could be instrumental in tolerance induction. However, anti-donor MHC cla
ss II alone prolonged graft survival but did not induce heart allograft tol
erance in this combination. We analyzed the immune response patterns in hea
rt allograft recipients following the injection of anti-donor class II anti
bodies (prolongation) or DST priming (tolerance). As suggested by the diffe
rent phenomena, several immunological patterns were strikingly different be
tween the two models. In strong contrast to DST-tolerant recipients, at 5 d
ays after transplantation, neither Th1/Th2 nor inflammatory cytokines were
inhibited in recipients treated with anti-donor class II antibodies, in whi
ch only prolongation of graft survival was induced. Nevertheless, in both m
odels, depletion of resident dendritic cells (DC) from donor hearts inhibit
ed tolerance induction (DST) or shortened allograft survival (anti-donor cl
ass II antibodies). Moreover, TGF-beta1 was not down-regulated and administ
ration of neutralizing anti-TGF-beta1 antibody, which inhibited tolerance i
nduction (DST), also shortened allograft survival (anti-donor class II anti
bodies). These results suggest that, in these two MHC class II-restricted m
odels, both TGF-beta1 and donor DC have a pivotal role in prolonging graft
survival. However, in the days following transplantation, further inhibitio
n of inflammatory cytokine production, particularly Th1 and macrophage-deri
ved cytokines is required for tolerance induction.